Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases Source: Annual Congress 2013 –Paediatric bronchology Year: 2013
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
Incidence of nasal polyposis and its association with the development of chronic bronchitis and/or emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002
Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps Source: Annual Congress 2011 - Epithelial cell biology Year: 2011
Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014
IL-19 as putative biomarker for chronic rhinosinusitis with nasal polyps Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Source: Eur Respir J 2008; 31: 70-77 Year: 2008
Beyond corticosteroids: future prospects in the management of inflammation in COPD Source: Eur Respir Rev 2011; 20: 175-182 Year: 2011
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
Revisited role for mucus hypersecretion in the pathogenesis of COPD Source: Eur Respir Rev 2009; 19: 109-112 Year: 2010
Relationship between epithelial TGF-ß1 expression and number of myofibroblasts in bronchial mucosa of children with chronic respiratory diseases Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015
Tiotropium inhibits airway inflammation and goblet cell metaplasia in a model of relapsing asthma in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
PPAR-alpha agonist (fenofibrate) therapy in exacerbation control of chronic obstructive pulmonary disease of severe stage Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Expression of heat shock proteins in chronic obstructive pulmonary disease, vernal keratoconjunctivitis and ulcerative colitis Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020
Alveolar macrophages phenotype in patients with asthma and its combination with gastroesophageal reflux disease with pulmonary manifestations Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015
Sublingual immunotherapy among patients, suffering from allergic rhinitis Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016